The use of phospholipid nanoparticles for increasing Semax resistance in various proteolytic biological media.
Shevchenko
K V
KV
Institute of Molecular Genetics, Russian Academy ofSciences, pl. Akademika Kurchatova 46, Moscow 123182, Russia.
Khrapko
A P
AP
Schwets
V I
VI
Myasoyedov
N F
NF
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism; D016503:Drug Delivery Systems; D004798:Enzymes / Q000097:blood; D007093:Imidazoles; D007931:Leucyl Aminopeptidase / Q000378:metabolism; D008081:Liposomes; D053758:Nanoparticles / Q000008:administration & dosage*; D009952:Ornithine / Q000031:analogs & derivatives; D010446:Peptide Fragments / Q000008:administration & dosage* / Q000378:metabolism; D010743:Phospholipids
D004798:Enzymes; D007093:Imidazoles; D008081:Liposomes; D010446:Peptide Fragments; D010743:Phospholipids; C107968:N(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithine; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone; D009952:Ornithine; D007931:Leucyl Aminopeptidase